PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

PAR Clinical Trial - Melbourne, page-46

  1. 4,249 Posts.
    lightbulb Created with Sketch. 6730
    Thanks Axle for sharing...I guess that's a start then...first time revenue lets go!

    Will be looking forward to tracking it....how?


    Quarterlies....

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.